Sarah Patel, MD
Sleep Medicine · Glendale, AZNPI 1487093175
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.7%), food and beverage and education — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 78.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $2,797 and has fallen 75.3% since, to $692 in 2025.
Across 66 payments — averaging $108.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$6K
- Inspire Medical Systems, Inc.$657
- Harmony Biosciences LLC$314
- Avadel CNS Pharmaceuticals, LLC$262
- Fisher & Paykel Healthcare Inc$107
- ZOLL Respicardia, Inc.$52
- plus $156 from 8 others
What the payments were for
- Consulting fees$3,98056%
- Food & beverage$2,86040%
- Education$3024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 29 | $5,594 |
| Inspire Medical Systems, Inc. | 11 | $657 |
| Harmony Biosciences LLC | 6 | $314 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $262 |
| Fisher & Paykel Healthcare Inc | 5 | $107 |
| ZOLL Respicardia, Inc. | 3 | $52 |
| Philips North America LLC | 2 | $50 |
| Nalu Medical, Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $20 |
| Electromed, Inc. | 1 | $18 |
| Biogen | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| 3b Medical, Inc. | 1 | $6 |
| Itamar Medical Inc | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,143 in reported general payments places this provider in the 75th percentile of 47 sleep medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SunosiSolriamfetol Hcl | 11 | $9,614 |
| Zolpidem Tartrate | 29 | $224 |
| Modafinil | 12 | $157 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 17 | $131 |
| Gabapentin | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Glendale
- Andrew ValenzuelaGlendale$5K
- Paul BhamrahGlendale$2K
- Vinod PatelGlendale$1K
- Jacqueline TricaricoGlendale$1K
- Ruchir PatelScottsdale$374K
- Joyce Lee-IannottiPhoenix$126K
- Chad RuoffScottsdale$55K
- Sairam ParthasarathyTucson$48K
- Jose de OcampoScottsdale$46K
- Jyotsna SahniTucson$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.